Synthetic Nanobots Could End Antibiotic Resistance
Futurism - 17-Nov-2017Most current antibiotics wipe out all bacteria - good and bad. French startup Eligo Bioscience i...
Join the club for FREE to access the whole archive and other member benefits.
Synthetic Biology company for targeted antimicrobials and microbiome editing.
Eligo Bioscience was created in 2014 based on the research from the Lu Lab (MIT) and the Marraffini Lab (Rockefeller University), which was later published in Nature Biotechnology.
Eligo was incubated at the Institut Pasteur in Paris from 2014 to 2017 and has moved in 2017 into the biotech cluster “Paris Biotech Santé” in the Cochin Hospital..
Visit website: https://eligo.bio/
Details last updated 01-May-2020
Most current antibiotics wipe out all bacteria - good and bad. French startup Eligo Bioscience i...
Founded in 2014, France-based Eligo Bioscience has received $20m Series A funding. Aims is to tr...